Alkermes

$18.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.24 (-1.26%) Today

-$0.03 (-0.14%) As of 9:30 PM UTC after-hours

Why Robinhood?

You can buy or sell Alkermes and other stocks, options, and ETFs commission-free!

About ALKS

Alkermes plc Ordinary Shares, also called Alkermes, is a biopharmaceutical company, which engages in the development, research, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. Its products include Aristada, which is used for the treatment of schizophrenia in adults; and Vivitrol, which is an injectable medication for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence, following opioid detoxification.

CEO

Richard F. Pops

Employees

2,245

Headquarters

Dublin, Dublin

Founded

2011

Market Cap

3.00B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.01M

High Today

$18.98

Low Today

$18.43

Open Price

$18.92

Volume

1.15M

52 Week High

$23.92

52 Week Low

$13.03

Analyst Ratings

9%

of 11 ratings

Buy

Hold

91%

Sell

ALKS Earnings

-$0.21

$0.14

$0.48

$0.83

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected Apr 28, Pre-Market